Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer ( <scp>KHBO1401</scp> ‐ <scp>MITSUBA</scp> )-Reference-Cited by-同舟云学术

Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer ( KHBO1401 ‐ MITSUBA )

Published:2022-08-09 Issue:1 Volume:30 Page:102-110
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepato Biliary Pancreat

Author:

Ioka Tatsuya¹²^ORCID,Kanai Masashi³,Kobayashi Shogo⁴,Sakai Daisuke⁵,Eguchi Hidetoshi⁶^ORCID,Baba Hideo⁷,Seo Satoru⁸^ORCID,Taketomi Akinobu⁹,Takayama Tadatoshi¹⁰,Yamaue Hiroki¹¹,Takahashi Masahiro¹²,Sho Masayuki¹³^ORCID,Kamei Keiko¹⁴,Fujimoto Jiro¹⁵,Toyoda Masanori¹⁶,Shimizu Junzo¹⁷,Goto Takuma¹⁸,Shindo Yoshitaro¹⁹^ORCID,Yoshimura Kenichi²⁰,Hatano Etsuro⁸,Nagano Hiroaki¹⁹,

Affiliation:

1. Department of Oncology Center Yamaguchi University Hospital Yamaguchi Japan

2. Department of Cancer Survey and Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan

3. Department of Medical Oncology Kyoto University Hospital Kyoto Japan

4. Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan

5. Department of Frontier Science for Cancer and Chemotherapy Osaka University Osaka Japan

6. Department of Gastroenterological Surgery Graduate School of Medicine, Osaka University Osaka Japan

7. Department of Gastroenterological Surgery Graduate School of Medical Science, Kumamoto University Kumamoto Japan

8. Department of Surgery Graduate School of Medicine, Kyoto University Kyoto Japan

9. Department of Gastroenterological Surgery I Hokkaido University Graduate School of Medicine Hokkaido Japan

10. Department of Digestive Surgery Nihon University School of Medicine Tokyo Japan

11. Second Department of Surgery, School of Medicine Wakayama Medical University Wakayama Japan

12. Department of Medical Oncology Tohoku University Hospital Sendai Japan

13. Department of Surgery Nara Medical University Nara Japan

14. Department of Surgery Kindai University Faculty of Medicine Osaka Japan

15. Department of Gastroenterological Surgery Hyogo College of Medicine Hyogo Japan

16. Department of Medical Oncology/Hematology Kobe University Hospital and Graduate School of Medicine Hyogo Japan

17. Department of Surgery Toyonaka Municipal Hospital Osaka Japan

18. Division of Gastroenterology and Hematology/Oncology Department of Medicine, Asahikawa Medical University Hokkaido Japan

19. Department of Gastroenterological, Breast and Endocrine Surgery Yamaguchi University Graduate School of Medicine Yamaguchi Japan

20. Medical Center for Clinical and Translational Research Hiroshima University Hospital Hiroshima Japan

Funder

Taiho Pharmaceutical

Publisher

Wiley

Subject

Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhbp.1219

Reference22 articles.

1. Prognostic Factors in Patients With Gallbladder Cancer After Surgical Resection

2. Essential updates to the surgical treatment of biliary tract cancer

3. Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations

4. Genetic analysis in the clinical management of biliary tract cancer

5. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary–pancreatic cancer;Surgical Case Reports;2024-01-26

2. Efficacy of S-1 Adjuvant Chemotherapy for Resected Biliary Tract Cancer: A Retrospective Propensity-Matched Analysis;The American Surgeon™;2024-01-16

3. Prolonged progression-free survival achieved by gemcitabine, cisplatin, and albumin-bound paclitaxel for the treatment of advanced biliary tract cancers;Therapeutic Advances in Medical Oncology;2024-01

4. Challenge for difficult-to-treat hepato-biliary-pancreatic cancer;Tenri Medical Bulletin;2023-12-25

5. Nutritional assessment and following nutritional intervention during drug therapy for patients with hepatobiliary carcinoma;The Japanese Journal of SURGICAL METABOLISM and NUTRITION;2023-12-15